Tag results:

AKT

TMEM116 Is Required for Lung Cancer Cell Motility and Metastasis through PDK1 Signaling Pathway

[Cell Death & Disease] Scientists demonstrated that transmembrane protein (TMEM) 116 was highly expressed in NSCLC tissues and cell lines.

Aberrant Promoter Hypermethylation Inhibits RGMA Expression and Contributes to Tumor Progression in Breast Cancer

[Oncogene] The authors found that RGMA was downregulated in breast cancer (BC) tissues compared with non-tumorous breast tissues, particularly in metastatic BC samples, and that patients with low RGMA expression manifested a poorer prognosis.

Chloroquine Potentiates the Anticancer Effect of Pterostilbene on Pancreatic Cancer by Inhibiting Autophagy and Downregulating the RAGE/STAT3 Pathway

[Molecules] Scientists investigated whether the autophagy inhibitor chloroquine could potentiate the anticancer effect of pterostilbene in the PDAC cell lines MIA PaCa-2 and BxPC-3, as well as in an orthotopic animal model.

The C-terminal HSP90 Inhibitor NCT-58 Kills Trastuzumab-Resistant Breast Cancer Stem-Like Cells

[Cell Death Discovery] Researchers investigated the capacity of NCT-58, a rationally-synthesized C-terminal HSP90 inhibitor, to kill trastuzumab-resistant HER2-positive breast cancer stem-like cells.

Tumor Suppressor LHX6 Upregulation Contributes to the Inhibitory Effect of miR-346 Knockdown on Colorectal Cancer Cell Growth

[Environmental Toxicology] Dysregulated miRNAs have been promulgated as oncogenes or tumor-suppressive genes participating in the initiation and progression of colorectal cancer (CRC). Scientists reported that miR-346 was highly expressed in CRC patients.

ROR2 Has a Protective Role in Melanoma by Inhibiting Akt Activity, Cell-Cycle Progression, and Proliferation

[Journal of Biomedical Science] The role of Receptor tyrosine kinase-like orphan receptor 2 (ROR2) in tumor growth was assessed in xenotransplantation experiments followed by immunohistochemistry analysis of the tumors.

Popular